Testingfor coronavirus will be ramped up amid criticism that NHS staff are being lost from the frontline over potentially harmless coughs, while private clinics report being inundated by people who can afford to pay for swab checks.
The Scottish Government says some Covid-19 testing on healthcare workers has already started at a local level anda national approach is being developed which will scale up these initial efforts.
It comes amid speculation that a new four-hour test could be made available in Britain.
Scotland reported its third coronavirus death on Wednesdayand First Minister Nicola Sturgeon confirmed schools across Scotland would close by the end of this week as a result of new advice from Government scientists.
They will also close in England, Wales and Northern Ireland.
Ms Sturgeon said many schools had reached a point where they have lost too many staff to continue as normal and would not necessarily reopen after Easter, or even before the summer holidays.
Prime Minister Boris Johnson said schools and nurseries across the UK would be expected to accommodate vulnerable children or the children of critical workers, such as NHS staff and police during the closure, with free school meals continuing to be provided to all eligible youngsters.
He added that exams would not go ahead as planned in May or June, but that pupils would get the qualifications they deserve.
Earlier Mr Johnson told the House of Commons the number of tests that can be carried out each day for coronavirus will be increased from 5,000 to 10,000, with a goal to expand it to 25,000 per day in England within four weeks.
North of the Border, there are three NHS laboratories currently processing tests and the Scottish Government is working with a range of partners to increase capacity to exceed 2,000 tests per day in the coming weeks.
A number of options to expand that further, and as quickly as possible, are being explored.
The Prime Minister said: We are prioritising testing of NHS staff for the obvious reason that we want them to be able to look after everybody else with confidence that theyre not transmitting the disease, and this country is actually far ahead of many other comparable countries in testing huge numbers of people.
It comes as a coronavirus test that reveals who has had Covid-19 but not shown symptoms is close to becoming available in a move being hailed as a game-changer.
The Governments chief scientific adviser, Sir Patrick Vallance, said Public Health Englands (PHE) work on the antibody test is progressing very fast, and will provide valuable insight into the pandemic.
Mr Johnson said: The great thing about having a test to see whether youve had it is suddenly a green light goes on above your head and you can go back to work safe and confident in the knowledge that you are most unlikely to get it again.
So for an economic point of view, from a social point of view, it really could be a game-changer.
You can really see the potential of that advance, which, as I say, is coming down the track.
Sir Patrick added: It is a gamechanger. And the reason its a gamechanger is that it allows you to understand the proportion of the asymptomatic population whos had this disease, but hasnt had symptoms.
Going forward its going to be critically important to be able to monitor this disease well because only by being able to monitor it can we start relaxing measuresagain.
The Scottish Government is increasing community surveillance by enabling 200 GP practices, representing a population of 1.2 million, to test patients for the virus.
Health Secretary Jeane Freeman has also promised to roll out testing to frontline NHS staff so that they do not self-isolate unnecessarily.
However, there has been criticism from medics that the process has been too slow and has left key services understaffed at a time when demand is soaring.
Glasgow GP Margaret McCartney tweeted: Our workload has increased 30-40 per cent in last two days.
I know everyone is very busy but a negative test in a symptomatic person would surely allow us to have a hope of functioning?
British Medical Association Scotland chairman Dr Lewis Morrison said: The impact Covid-19 will have on the NHS could be huge. Frontline workers will be working in very different ways and we will need every pair of hands we can possibly get at this time.
That is why it is essential for NHS staff to be tested for the virus if they suspect they have it.
The Scottish Government has assured us this will happen and we now need to see the details of how staff can access testing as soon as possible, to minimise the number of NHS staff who would otherwise be self-isolating.
Professor Michael Griffin, president of the Royal College of Surgeons Edinburgh, said: The recommendation from the UK Government on Monday that pregnant women should self-isolate, as well as a 14-day isolation of those who have been exposed to family members with symptoms, though understandable, has already put a huge pressure on the NHS workforce.
Thats why its absolutely imperative that healthcare workers are tested for Covid-19 to confirm whether they are infected in order to help prevent the unnecessary exclusion of essential NHS staff at the frontline when the epidemic hits its peak.
A test is available for 375 at the Private Harley Street Clinic in London.
Mark Ali, a doctor at the clinic, said it had been inundated with requests for the test, which can be couriered to and from a client for them to take swabs from their own nose and throat.
Mr Ali said: We are testing lords and ladies, knights, and even doctors and dentists who are worried about catching the disease.
As of March 12, the UK had tested just under 30,000 people more than any other European nation except Italy, which had tested 86,000 and Russia which had tested 80,000.
The US had tested fewer than 14,000 in official Centre for Disease Control (CDC) laboratories, compared to 250,000 in South Korea.
Scotland has carried out 6,091 tests to date. US firm ThermoFisher held talks this week with the Prime Minister, HealthSecretary Matt Hancock, Chief Medical Officer Chris Whitty, Chief Scientific Advisor Sir Patrick Vallance and representatives from Boots, Amazon and pharmaceutical giant Roche.
The firm is believed to have been demonstrating its four-hour testing kit which has been approved for use in the US.
The UK death toll from the virus has reached 104 exceeding 100 for the first time and the number of new cases is accelerating, with 676 new cases confirmed yesterday.
Organisers announced that the Glastonbury music festival and Eurovision Song Contest would not go ahead due to the coronavirus outbreak, with filming also suspended temporarily on BBC soaps including Eastenders and Casualty.
It comes as Chinas top coronavirus expert has warned that herd immunity will not contain the global pandemic because the disease is highly infectious and lethal.
Dr Zhong Nanshan, Chinas senior medical adviser, said: We dont yet have the evidence to prove that if you are infected once, you would be immune for life.
Clinical trials for potential vaccines are under way in China and the US, but is not expected to be ready until at least 2021.
Meanwhile, an antiviral drug used in Japan to treat influenza has shown potential to speed recovery from the novel coronavirus that causes Covid-19. The drug, called called Favipiravir or Avigan, was tested on 340 people in China who had been diagnosed with Covid-19.
Half tested negative for the virus within four days of being given the drug compared to 11 days for the patients not on the antiviral.
Lung conditions were also shown in X-rays to have improved in 91 per cent of participants.
There were also claims in China that patients could be cured using stem cell therapy.
Dr Dongcheng Wu, a doctor and stem cell expert based in Wuhan, the epicentre of the outbreak, said he had successfully treated nine patients who were hospitalised with novel coronavirus pneumonia.
All nine reportedly made a full recovery following stem cell transplants and conventional treatment. Dr Wu said: Yes, it is a cure but it is still very early in the process.
It came as Italy recorded 475 coronavirus deaths in a single day the highest 24-hour spike for any country since the infection emerged in China.
Read more here:
Coronavirus tests stepped up to stop exodus of frontline NHS staff - HeraldScotland
- BIORESTORATIVE THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K) - Marketscreener.com - March 29th, 2023
- Induced Pluripotent Stem Cell for the Study and Treatment of ... - Hindawi - December 3rd, 2022
- What Happens When Everyone Realises We Can Live Much Longer? We May Find Out As Soon As 2025 - Forbes - December 3rd, 2022
- INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com - November 17th, 2022
- 3D Cell Culture Market stands at revenue of US$ 1.15 Bn in 2022, and is predicted to surge at a CAGR of 9.8% to hit worth of US$ 2.67 Bn during... - November 17th, 2022
- YUBO INTERNATIONAL BIOTECH LTD Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - Marketscreener.com - November 17th, 2022
- ACTINIUM PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-Q) - Marketscreener.com - November 17th, 2022
- Top 10 Best Stem Cell Supplement Brands - Healthtrends - June 26th, 2022
- How Does Stem Cell Therapy Work and What Are the Risks? | ISCRM - June 26th, 2022
- Stem Cell Wellness Kit - June 26th, 2022
- Kangstem Biotech withdraws trial application for stem cell-based osteoarthritis treatment - KBR - June 26th, 2022
- Global Human Embryonic Stem Cell Market to be Driven by the Rapid Technological Advancements in the Forecast Period of 2022-2027 Designer Women -... - June 26th, 2022
- Sana Biotechnology Announces Multiple Preclinical Data Presentations to Showcase Its Hypoimmune Platform, Including in Type 1 Diabetes, at the... - June 26th, 2022
- Efficient terminal erythroid differentiation requires the APC/C cofactor Cdh1 to limit replicative stress in erythroblasts | Scientific Reports -... - June 26th, 2022
- Propanc Biopharma's CSO Hails Dostarlimab's Impressive Results Whilst Acknowledging More Work to Be Done in the Fight Against Cancer - Business Wire - June 26th, 2022
- Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including... - June 26th, 2022
- 10 Years of Immunotherapy: Advances, Innovations, and Better Patient Outcomes - Targeted Oncology - June 26th, 2022
- Embryonic Stem Cell Research: An Ethical Dilemma - January 30th, 2022
- Skeletal Muscle Cell Induction from Pluripotent Stem Cells - January 30th, 2022
- mRNA COVID-19 Vaccine Effectiveness in the Immunocompromised - Medscape - January 30th, 2022
- MaaT Pharma Announces Positive Interim Engraftment Data for Oral Formulation MaaT033 Allowing Early Termination of Phase 1b CIMON Study - Business... - January 30th, 2022
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following... - January 30th, 2022
- Targeted Therapy Innovator Foresees New Paradigms in Breast Cancer - OncLive - January 30th, 2022
- Global Circulating Tumor Cells (CTC) Market Growing Demand, Future Trends, Competitive Regions and Forecast 2021 to 2027 The Oxford Spokesman - The... - January 30th, 2022
- Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer |... - December 8th, 2021
- All at-risk TN-bound travellers test Covid negative - The New Indian Express - December 8th, 2021
- Good Stocks To Invest In Right Now? 4 Health Care Stocks To Check Out - FW Business - December 8th, 2021
- Pandemic lockdown declined emotional well-being for adults with hearing, vision loss: Study - ETHealthworld.com - December 8th, 2021
- Impact of microbial contamination of haematopoietic stem cells on post-transplant outcomes: A retrospective study from tertiary care centre in India -... - August 17th, 2021
- Longeveron: Time to Buy the Di - GuruFocus.com - August 17th, 2021
- The latest on the Covid-19 pandemic in the US: Live updates - CNN - August 17th, 2021
- How this Holocaust refugee beat Covid-19 against all odds J. - The Jewish News of Northern California - August 17th, 2021
- Trade-offs among transport, support, and storage in xylem from shrubs in a semiarid chaparral environment tested with structural equation modeling -... - August 17th, 2021
- Oklahoma 10-year-old in remission after being diagnosed with rare form of leukemia 2 years ago - KFOR Oklahoma City - July 21st, 2021
- Covid: There's a serious problem with how we are testing people for the virus Neale Hanvey MP - The Scotsman - July 21st, 2021
- Profilin 1 Protein and Its Implications for Cancers - Cancer Network - July 21st, 2021
- Homing Technology Delivers Therapy to Cancerous Bone - The Scientist - July 21st, 2021
- Developmental Interest in Allogeneic PlacentaDerived Cell Therapies Expands - OncLive - July 21st, 2021
- Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches - DocWire News - July 21st, 2021
- The World's First Lab-Grown Foie Gras Could Solve This Major Concern - Mashed - July 21st, 2021
- KEYTRUDA (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery Showed Statistically Significant Event-Free... - July 21st, 2021
- Human Mesenchymal Stem Cells (hMSC) Market Size 2021 | Global Trends, Business Overview, Challenges, Opportunities and Forecast to 2027 The Bisouv... - March 3rd, 2021
- [Full text] An Update on the Molecular Pathology of Metaplastic Breast Cancer | BCTT - Dove Medical Press - March 3rd, 2021
- 4D Pharma Appointments Paul Maier to the Board as Non-Executive Director - Business Wire - March 3rd, 2021
- Investigative Interventions Gain Ground in GVHD - OncLive - March 3rd, 2021
- Combination Regimens for Multiple Myeloma Show Efficacy in the Transplant-Ineligible Population, According to Dingli - Targeted Oncology - March 3rd, 2021
- Martin Makes Sense of the Rapidly Evolving MCL Treatment Paradigm - OncLive - March 3rd, 2021
- Hoth Therapeutics Expands License Agreement to Include Innovative Cancer and Anaphylactic Treatment - BioSpace - March 3rd, 2021
- Health Matters; Inflammation with Dr. Baumgartner [PODCAST] - WJON News - February 14th, 2021
- G1 Therapeutics gains first FDA nod with myelopreservation therapy Cosela | 2021-02-12 - BioWorld Online - February 14th, 2021
- Kris Gopalakrishnan on innovation - Fortune India - February 14th, 2021
- Change is coming, and at an ever-accelerating pace - Al Jazeera English - January 12th, 2021
- MCL Landscape Adapts to Changes After CAR T-Cell Therapy Approval - OncLive - January 9th, 2021
- 5 questions facing gene therapy in 2021 - BioPharma Dive - January 9th, 2021
- RNA molecules are masters of their own destiny - MIT News - January 9th, 2021
- Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market: Industry Analysis and Forecast (2019-2026): By indication type, treatment type,... - January 9th, 2021
- Harpoon Therapeutics : Clin Cancer Res 2021; OnlineFirst version Jan 6, 2021 - Marketscreener.com - January 9th, 2021
- Synthetic lethality across normal tissues is strongly associated with cancer risk, onset, and tumor suppressor specificity - Science Advances - January 5th, 2021
- Versiti Blood Centers and Noodles & Company Serve Up Thanks to Blood Donors - PRNewswire - January 5th, 2021
- January 2021: 2020 Papers of the Year - Environmental Factor Newsletter - January 5th, 2021
- Ozone in the air is bad for birds - Massive Science - January 5th, 2021
- How good are the COVID-19 vaccines? - Massive Science - January 5th, 2021
- Stem cells from cord blood can now be used across many conditions: Mayur Abhaya, MD & CEO, LifeCell Internat.. - ETHealthworld.com - December 28th, 2020
- Allogeneic SCT Benefits Children and Adolescents With Relapsed Anaplastic Large Cell Lymphoma - OncLive - December 28th, 2020
- CalvinAyre.com's most read life stories of 2020 - CalvinAyre.com - December 28th, 2020
- Coronavirus | Over 6,000 travellers from U.K. traced across States - The Hindu - December 28th, 2020
- Exosomes act as messengers and decoys to save healthy cells from viral infection - Massive Science - December 28th, 2020
- Celtics adjust to two-game series designed to reduce team travel - The Boston Globe - December 28th, 2020
- Experts Reflect on Most Impactful FDA Moves of 2020 in Solid Tumors, Hematologic Malignancies - Targeted Oncology - December 28th, 2020
- FDA Resumes eIND Approval for Severe-to-Critical COVID-19 Patients Use of Vyrologix (leronlimab) Following Full Enrollment in CytoDyn's Phase 3 Trial... - December 28th, 2020
- Magenta Therapeutics Announces Commencement of First Phase 2 Clinical Trial of MGTA-145 for Stem Cell Mobilization, Oral Presentation of MGTA-145... - December 12th, 2020
- Daratumumab Regimen Shows Promise in Transplant-Eligible Patients With Newly Diagnosed Myeloma - Targeted Oncology - December 12th, 2020
- HSCT Found Potentially Curative for Some T-Cell Lymphoma Patients - Cancer Therapy Advisor - December 12th, 2020
- Researchers Trace the Origin of Blood Cancer to Early Childhood, Decades before Diagnosis - Yahoo Finance - December 12th, 2020
- ALLO-715, Off-the-Shelf CAR T-Cell Therapy, Produces Early Promise in Multiple Myeloma - Cancer Network - December 12th, 2020
- BeiGene Announces the Approval in China of BLINCYTO (Blinatumomab) for Injection for Adult Patients with Relapsed or Refractory B-Cell Precursor Acute... - December 12th, 2020
- Flintshire youngster goes the extra mile to raise funds for Lymphoma Action | The Leader - LeaderLive - December 12th, 2020
- Meat-Tech Agrees to Acquire Cultured Fat Pioneer 'Peace of Meat' - PRNewswire - December 12th, 2020
- Stem Cell Manufacturing Market Size, Overview with Detailed Analysis, Competitive landscape, Forecast to 2027 - Cheshire Media - December 12th, 2020
- Rocket Pharmaceuticals Presents Positive Clinical Data from its Fanconi Anemia and Leukocyte Adhesion Deficiency-I Programs at the 62nd American... - December 12th, 2020